MAPK3, mitogen-activated protein kinase 3, 5595

N. diseases: 647; N. variants: 7
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0025286
Disease: Meningioma
Meningioma
0.040 GeneticVariation disease BEFREE Frequent AKT1E17K mutations in skull base meningiomas are associated with mTOR and ERK1/2 activation and reduced time to tumor recurrence. 28482067 2017
CUI: C0025286
Disease: Meningioma
Meningioma
0.040 Biomarker disease BEFREE The suppressive action of paclitaxel on meningioma cell growth was enhanced in the presence of fluvastatin or the mitogen-actvated protein kinase (ERK1/2) inhibitor PD98059. 18688857 2008
CUI: C0025286
Disease: Meningioma
Meningioma
0.040 AlteredExpression disease BEFREE In conclusion, we found that human meningiomas express CXCR4 and SDF1 and that hSDF1alpha induces proliferation in primary meningioma cell cultures through the activation of ERK1/2. 17108064 2007
CUI: C0025286
Disease: Meningioma
Meningioma
0.040 Biomarker disease BEFREE Considering the critical importance of the Erk-1/2 signal transduction pathway not only in meningiomas but in other human neoplasms, the interruption of signaling through this evolutionarily conserved pathway might be one of the mechanisms by which AKBA induces suppression of proliferation and apoptosis of different tumor types. 12664615 2002